What do you mean by “built a facility?” Can you link to that? I keep seeing people tout that but I’m unclear on why that would even be necessary?
The press release says they are “opening a research facility” and that it’s goal is to “centralize research and development” on “hair regenerative medicine with an aim of commercialization.”
So, the way I read it, basically they opened an office in an existing Japanese biomedical corporate park (Kobe Biomedical Innovation Cluster), where they will research and develop hair regeneration generally, not just the Replicel tech. It sounds pretty broad and not really as grandiose as many of you make it sound.
If you have more info than what’s in the press release (
https://www.shiseidogroup.com/releimg/2289-e.pdf) please link to it so I can understand better what exactly they “built” and what constitutes a “facility” in this case?
My impression of the RCH-01 technology is that it’s pretty straightforward - extract the cells from the safe zone, inject them into the balding areas. I’m not sure how a facility is necessary other than housing the cellular material.